Michael H. Ullmann - 14 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: Exec VP, General Counsel
Issuer ticker: JNJ
Reported as of: 14 Feb 2022
Net transaction value: +$7,409,477
SEC form: 4
Accepted by SEC: 17 Feb 2022, 05:00:35 UTC
Source filing: View source filing
Reporting owner signature: Raavi K. Deol, as attorney-in-fact for Michael H. Ullmann

Key filing fact

Michael H. Ullmann filed Form 4 for JOHNSON & JOHNSON (JNJ) on 17 Feb 2022.

Key facts

This page summarizes Michael H. Ullmann's Form 4 filing for JOHNSON & JOHNSON (JNJ).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 17 Feb 2022, 05:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$7,409,477.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JNJ transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +13,186
Change %: +8.7%
Price: $0.000000
Shares after: 165,044
Date: 15 Feb 2022
Ownership: Direct
Footnotes: F1

JNJ transaction

Common Stock

Tax liability

Transaction value: $1,030,011
Shares: -6,209
Change %: -3.8%
Price: $165.89
Shares after: 158,835
Date: 15 Feb 2022
Ownership: Direct
Footnotes: F2

JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 433
Date: 14 Feb 2022
Ownership: By 401k
Footnotes: F3

JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,287
Date: 14 Feb 2022
Ownership: By ESOP
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Award

Transaction value: $8,439,488
Shares: +50,874
Change %
Price: $165.89
Shares after: 50,874
Date: 14 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,874
Exercise price
Footnotes: F5

JNJ transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +2,575
Change %
Price: $0.000000
Shares after: 2,575
Date: 14 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,575
Exercise price
Footnotes: F6

JNJ transaction Derivative

Performance Share Units

Options Exercise

Transaction value: $0
Shares: -13,186
Change %: -91%
Price: $0.000000
Shares after: 1,257
Date: 15 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,186
Exercise price
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Footnote F2

Shares withheld for payment of taxes upon vesting of Performance Share Units.

Footnote F3

Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).

Footnote F4

Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).

Footnote F5

Awarded under Issuer's Long-Term Incentive Plan.

Footnote F6

Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Footnote F7

Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.